Selectquote, Inc. (SLQT) — SEC Filings

Selectquote, Inc. (SLQT) — 20 SEC filings. Latest: 8-K (Mar 25, 2026). Includes 9 8-K, 6 10-Q, 2 DEF 14A.

View Selectquote, Inc. on SEC EDGAR

Overview

Selectquote, Inc. (SLQT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 25, 2026: SelectQuote, Inc. (CIK: 0001794783) filed an 8-K on March 25, 2026, announcing a notice of delisting or failure to satisfy a continued listing rule or standard, effective March 19, 2026. This means the company is no longer meeting the requirements to be traded on its current stock exchange, which co

Sentiment Summary

Across 20 filings, the sentiment breakdown is: 3 bearish, 17 neutral. The dominant filing sentiment for Selectquote, Inc. is neutral.

Filing Type Overview

Selectquote, Inc. (SLQT) has filed 9 8-K, 6 10-Q, 2 DEF 14A, 1 8-K/A, 1 10-K, 1 SC 13G/A with the SEC between Jan 2024 to Mar 2026.

Filings by Year

2026 · 2025 · 2024

Recent SEC Filings (20)

Selectquote, Inc. SEC Filing History
DateFormDescriptionRisk
Mar 25, 20268-KSelectQuote Faces Delisting Notice, Listing Rule Violation
Nov 14, 20258-KSelectQuote Files 8-K on Shareholder Vote Matterslow
Nov 6, 202510-QSelectQuote's Q1 Loss Widens on Operating Costs, Despite Revenue Jumphigh
Oct 2, 2025DEF 14ASelectQuote Sets Virtual 2025 Annual Meeting, Board Backs All Proposalslow
Aug 21, 20258-KSelectQuote Files 8-K on Financialslow
Jul 29, 20258-KSelectQuote Enters Material Definitive Agreementmedium
Jul 2, 20258-KSelectQuote Files 8-K for Financial Statementslow
May 12, 202510-QSelectQuote Faces DOJ Lawsuit Over Medicare Marketinghigh
Feb 28, 20258-KSelectQuote Files 8-K: Agreements, Equity Sales, Officer Changesmedium
Feb 10, 202510-QSelectQuote Files Q2 2025 10-Qmedium
Nov 18, 20248-KSelectQuote Files 8-K on Shareholder Voteslow
Nov 4, 202410-QSelectQuote Files Q1 2025 10-Qmedium
Oct 18, 20248-K/ASelectQuote Files 8-K/A Amendmentmedium
Oct 16, 20248-KSelectQuote Files 8-K: Material Agreement, Financial Obligation, Equity Salesmedium
Oct 2, 2024DEF 14ASelectQuote Files Definitive Proxy Statementlow
Sep 13, 202410-KSelectQuote Files 2024 Annual Reportmedium
May 9, 202410-QSelectQuote, Inc. Files 10-Q for Period Ending March 31, 2024medium
Feb 8, 202410-QSelectQuote, Inc. Files 10-Q for Period Ending December 31, 2023medium
Feb 7, 20248-KSelectQuote Files 8-K on Financial Results
Jan 29, 2024SC 13G/ABlackRock Amends SelectQuote Stake: Passive Investment Update

Risk Profile

Risk Assessment: Of SLQT's 17 recent filings, 2 were flagged as high-risk, 9 as medium-risk, and 6 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.

Financial Highlights

Selectquote, Inc. Financial Summary (10-Q, Nov 6, 2025)
MetricValue
Revenue$328.8M
Net Income-$47.9M
EPS-$0.26
Debt-to-Equity2.16
Cash Position$15.7M
Operating Margin-12.4%
Total Assets$1.207B
Total Debt$393.1M

Key Executives

  • Timothy R. Danker
  • Denise L. Devine
  • Donald L. Hawks III
  • Ryan M. Clement
  • Daniel A. Boulware

Industry Context

SelectQuote operates in the insurance brokerage industry, which is highly competitive and subject to evolving regulatory landscapes. The industry is characterized by a shift towards digital channels for customer acquisition and policy management. Trends include increasing demand for Medicare Advantage plans and a growing reliance on technology to streamline quoting and enrollment processes.

Top Tags

material-agreement (4) · 10-Q (4) · sec-filing (3) · financial-obligation (3) · financials (3) · corporate-governance (2) · shareholder-vote (2) · Quarterly Earnings (2) · equity-sale (2) · quarterly-report (2)

Key Numbers

Selectquote, Inc. Key Metrics
MetricValueContext
SEC File Number001-39295Identifies the company's filing with the SEC.
EIN94-3339273Employer Identification Number for SelectQuote, Inc.
Total Revenue$328.8MIncreased by 12.5% from $292.3 million year-over-year
Pharmacy Revenue$218.5MIncreased by 42.9% from $152.9 million year-over-year
Commissions and Other Services Revenue$110.3MDecreased by 20.9% from $139.4 million year-over-year
Loss from Operations$40.7MWidened from $12.0 million in the prior year
Net Loss Attributable to Common Shareholders$47.9MIncreased from $44.5 million in the prior year
Net Loss Per Share (Basic and Diluted)$0.26Remained consistent with the prior year despite higher net loss due to increased shares outstanding
Cash, Cash Equivalents, and Restricted Cash$15.7MDecreased from $37.1 million at the beginning of the period
Net Cash Used in Operating Activities$21.6MIncreased from $16.6 million in the prior year
Shares of Common Stock Outstanding175,971,744As of October 31, 2025
Date of 2025 Annual MeetingNovember 11, 2025Meeting will be held at 9:00 a.m. Central Time
Record Date for voting eligibilitySeptember 23, 2025Stockholders of record at close of business on this date can vote
Shares of common stock outstanding175,884,846As of the Record Date, entitled to vote at the Annual Meeting
Fee for proxy solicitor Georgeson LLC$16,000Expected payment for proxy solicitation services, plus reasonable expenses

Forward-Looking Statements

  • {"claim":"SelectQuote will continue to focus on its Service and Pharmacy segments for revenue generation.","entity":"SelectQuote, Inc.","targetDate":"2024-06-30","confidence":"high"}

Related Companies

FULT

Frequently Asked Questions

What are the latest SEC filings for Selectquote, Inc. (SLQT)?

Selectquote, Inc. has 20 recent SEC filings from Jan 2024 to Mar 2026, including 9 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of SLQT filings?

Across 20 filings, the sentiment breakdown is: 3 bearish, 17 neutral. The dominant sentiment is neutral.

Where can I find Selectquote, Inc. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Selectquote, Inc. (SLQT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Selectquote, Inc.?

Key financial highlights from Selectquote, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for SLQT?

The investment thesis for SLQT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Selectquote, Inc.?

Key executives identified across Selectquote, Inc.'s filings include Timothy R. Danker, Denise L. Devine, Donald L. Hawks III, Ryan M. Clement, Daniel A. Boulware.

What are the main risk factors for Selectquote, Inc. stock?

Of SLQT's 17 assessed filings, 2 were flagged high-risk, 9 medium-risk, and 6 low-risk.

What are recent predictions and forward guidance from Selectquote, Inc.?

Recent forward-looking statements from Selectquote, Inc. include guidance on {"claim":"SelectQuote will continue to focus on its Service and Pharmacy segments for revenue generation.","entity":"Sel.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.